After six days of gains, shares dropped, reflecting mixed momentum. See insights on earnings, cost-cutting, and analyst ...

The UK’s National Institute for Health and Care Excellence (NICE) has today (August 21) recommended the use of Japanese pharma major Astellas’ enfortumab vedotin with MSD’s Keytruda (pembrolizumab) ...

GMO’s 13F portfolio grew to $33.23B in Q2 2025, with Microsoft, Meta, Alphabet, Oracle, and Apple as top holdings. Read more about the portfolio here.

Additionally, a study published in July 2025 examined the use of methotrexate as first-line treatment for pulmonary ...

New food hygiene ratings have been awarded to three of Redcar and Cleveland’s establishments, the Food Standards Agency’s ...

Veeva Systems (NYSE: VEEV) today announced highlights of its upcoming Veeva R&D and Quality Summit, where leaders across life sciences and Veeva exchange impactful ideas and innovations. BeOne ...

Dow ETFs vary widely, giving investors choices between stability, income generation or leverage keyed to the index.

Merck & Co Inc. saw its shares climb, signaling a shift toward value and income in the market. The stock opened at $84.38 and maintained this as its low, showing a strong floor of support from the ...